Sekisui Chemical Co (FRA:SUI) Operating Income: €600 Mil (TTM As of Mar. 2026)


FRA:SUI Sekisui Chemical Co Ltd FRA:SUI
77 GF Score
Price €14.20
GF Value €13.38
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sekisui Chemical Co Operating Income?

Sekisui Chemical Co FRA:SUI -0.70% 77 Operating Income is €600 Mil as of Mar. 2026. GuruFocus rates FRA:SUI with a GF Score™ of 77/100 and a GF Value™ of €13.38 (Fairly Valued). The stock has 2 warning signs investors should review.

Sekisui Chemical Co's Operating Income for the three months ended in Mar. 2026 was €183 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was €600 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Sekisui Chemical Co's Operating Income for the three months ended in Mar. 2026 was €183 Mil. Sekisui Chemical Co's Revenue for the three months ended in Mar. 2026 was €1,904 Mil. Therefore, Sekisui Chemical Co's Operating Margin % for the quarter that ended in Mar. 2026 was 9.61%.

Good Sign:

Sekisui Chemical Co Ltd operating margin is expanding. Margin expansion is usually a good sign.

Sekisui Chemical Co's 5-Year average Growth Rate for Operating Margin % was 4.30% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sekisui Chemical Co's annualized ROC % for the quarter that ended in Mar. 2026 was 8.04%. Sekisui Chemical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 21.81%.

Sekisui Chemical Co  (FRA:SUI) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sekisui Chemical Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=732.044 * ( 1 - 28.58% )/( (6437.034 + 6568.203)/ 2 )
=522.8258248/6502.6185
=8.04 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7688.366 - 649.531 - ( 601.801 - max(0, 2111.565 - 3884.466+601.801))
=6437.034

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7783.848 - 685.839 - ( 529.806 - max(0, 2118.222 - 3934.069+529.806))
=6568.203

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Sekisui Chemical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=861.3/( ( (2453.571 + max(1447.284, 0)) + (2521.426 + max(1475.528, 0)) )/ 2 )
=861.3/( ( 3900.855 + 3996.954 )/ 2 )
=861.3/3948.9045
=21.81 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1135.289 + 1900.72 + 207.257) - (649.531 + 0 + 1146.451)
=1447.284

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1163.767 + 1929.242 + 304.816) - (685.839 + 0 + 1236.458)
=1475.528

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Sekisui Chemical Co's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=183.011/1904.483
=9.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Sekisui Chemical Co Operating Income Related Terms

Sekisui Chemical Co Operating Income Historical Data

* Premium members only.

The historical data trend for Sekisui Chemical Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sekisui Chemical Co Operating Income Chart

Sekisui Chemical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 680.59 640.53 579.69 669.91 580.42

Sekisui Chemical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 189.84 127.34 139.60 150.39 183.01
FRA:SUI
77GF Score
Sekisui Chemical Co Ltd FRA:SUI
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sekisui Chemical Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €600 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of €600 Mil mean?
Sekisui Chemical Co (FRA:SUI) has a Operating Income of €600 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Sekisui Chemical Co and its competitors.
Is Sekisui Chemical Co's Operating Income too high?
Sekisui Chemical Co's current Operating Income is €600 Mil. Overall, Sekisui Chemical Co has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sekisui Chemical Co's Operating Income compare to HON and MMM?
Sekisui Chemical Co's Operating Income of €600 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Conglomerates company?
A good Operating Income depends on the Conglomerates industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Sekisui Chemical Co and its competitors. Sekisui Chemical Co's current Operating Income is €600 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sekisui Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Sekisui Chemical Co (FRA:SUI) is currently considered Fairly Valued. The stock's GF Value™ is €13.38, compared to a current price of €14.20 — trading 6.1% above its estimated fair value. The current Operating Income is €600 Mil. Sekisui Chemical Co's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Sekisui Chemical Co (FRA:SUI), the current Operating Income is €600 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sekisui Chemical Co (FRA:SUI) Overvalued in 2026?

Based on GuruFocus' analysis, Sekisui Chemical Co stock appears to be overvalued. The current stock price of €14.20 is trading 6.1% above its estimated GF Value™ of €13.38. GuruFocus considers Sekisui Chemical Co to be Fairly Valued.

Key valuation signals for FRA:SUI:

  • Operating Income: €600 Mil
  • GF Value™: €13.38 vs. price of €14.20 (6.1% above fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the FRA:SUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sekisui Chemical Co Business Description

Address 2-4-4 Nishitenma, Kita-ku, Osaka, JPN, 530-8565
Sekisui Chemical Co Ltd is a Japanese diversified holding company engaged in the housing, infrastructure, high-performance plastics, and medical businesses. The company operates through four segments: Housing, which handles the manufacture, sale, and renovation of unit housing and real estate services; Environment & Lifeline, which produces and sells plastic pipes, building materials, and infrastructure products; High Performance Plastics, which manufactures glass interlayer films, polyolefin foams, adhesive tapes, and functional materials; and Medical, which produces and sells diagnostic reagents, medical raw materials, and pharmaceutical intermediates. It generates the majority of its revenue from the Housing segment.
77GF Score

Get the complete analysis for FRA:SUI

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.20
Price
€13.38
GF Value